Dr Wayengera (CDF1545) meets His Excellency President Museveni, President of Uganda
President Museveni has congratulated Dr. Misaki Wayengera, a Researcher at Makerere University College of Health Sciences, for his efforts in developing a rapid test kit to diagnose the deadly Ebola and Marburg viruses. Dr Wayengera is an EDCTP Career Development Fellow (TMA2016CDF1545).
“I want to congratulate our scientists because they are really waking up and producing a lot of products. The Government will fund you. It is the issue of prioritization and putting the money in the right place,” he said. The President was on Tuesday speaking during a meeting at State House, Entebbe to recognize Dr. Misaki Wayengera who recently won the World Health Organization (WHO) high innovation challenge in Product Development Category that took place at the WHO Africa Regional Headquarters in Congo (Brazzaville).
Dr Wayengera’s invention also known as Pan-Filovirus Rapid Diagnostic Test, uses a paper-strip test, like the one used in testing for pregnancy. This, however, will be used in detecting Ebola, Marburg and other hemorrhagic fevers. Africa has had several hemorrhagic fever outbreaks especially Ebola Virus Disease (EVD) with the latest and ongoing outbreak currently in the Democratic Republic of Congo that borders Uganda to the West. Rapid diagnosis is important in informing key decisions especially interventions and measures to take in the event of a disease outbreak. If approved by health authorities including the World Health Organization (WHO) and partners, Dr Wayengera’s Pan-Filovirus Rapid Diagnostic Test will go a long way in improving rapid tests and turnaround time for results during disease outbreaks. President Museveni said that the Government of Uganda will support the efforts of the researchers by establishing a manufacturing facility that will enable them to put all the products together. He commended Dr. Wayengera and his team on the achievements realized adding that the research can bring in a host of benefits to society because the products form the core that addresses many human challenges such as hemorrhage fevers and HIV afflictions that immensely affect the world. The President observed that Uganda has, on several occasions, been attacked by epidemics, including Ebola and Marburg, resulting in the deaths of trained preventive workers and wananchi. State Minister for Health, Hon. Sarah Ochieng Opendi, saluted Dr. Wayengera and his team for the innovation saying their efforts will go a long way in easing the diagnosis of viral hemorrhage fevers such as Ebola and Marburg. Dr. Wayengera, on his part, thanked President Museveni for recognizing their efforts and his support.
Articles
Prof. George Boateng Kyei: Advancing Hiv Research In Africa
In his EDCTP-GSK Senior Fellowship, Professor George Boateng Kyei of the Noguchi Memorial Institute for Medical Research, University of Ghana, has not only advanced the search for an HIV cure but also strengthened research capacity across Ghana and the broader African region.
Addressing HIV persistence
HIV remains a pressing public health issue in Africa, with persistent challenges hindering the quest for a cure. This fellowship project focused on one such challenge: the virus’s ability to remain dormant within resting CD4+ T cells, even among individuals receiving antiretroviral therapy (ART). By exploring the innovative “shock and kill” approach, the research aimed to reactivate latent HIV and target infected cells for destruction. A notable scientific achievement was the identification and confirmation of three novel epigenetic compounds capable of reactivating latent HIV from virologically suppressed individuals. These findings pave the way for future studies in animal models, with the potential to transition into clinical trials aiming at finding a cure for HIV.
Strengthening research infrastructure
The establishment of a drug screening platform at the University of Ghana stands out as a long-term asset for HIV drug discovery and cure research. Additionally, the project introduced regular viral load monitoring for a substantial cohort of patients—an essential practice previously not standard in Ghana. The data generated from this monitoring has been instrumental in shaping national HIV treatment policies and improving patient care.
Furthermore, the project developed a biobank and a well-characterised cohort of HIV-infected adults, providing invaluable resources for ongoing and future HIV cure research. Insights gathered from patients regarding their perceptions of HIV cure research will inform the design and conduct of subsequent studies in Ghana and across Africa.
Training the next generation of researchers
The impact of the fellowship extends beyond laboratory accomplishments; it has significantly influenced research training and career development. The fellowship helped nurture the growth of junior scientists, many of whom have evolved into independent research leaders, securing competitive grants and fellowships, such as the IAS Research-for-Cure Academy and NIH R21. They have presented their findings at prestigious international conferences, including the African Virology Congress and the American Society of Tropical Medicine and Hygiene (ASTMH).
Post-doctoral fellows have notably received fellowships from esteemed international programmes, such as the Science by Women Fellowship and the NIH CFAR Africure award, showcasing their growing prominence in the research community.
Recognition and awards
Professor Kyei’s mentorship has not gone unnoticed; in April 2024, he received special recognition from the University of Ghana’s Centre for Gender Studies and Advocacy (CEGENSA) for his outstanding mentorship of female academics—an honour highlighted by nominations from his own mentees. The project also celebrated the achievements of its team members, with one post-doc winning Best Senior Research Fellow at the 2024 NMIMR Awards and research assistants earning accolades at the 2024 African Virologist Conference.
Professor Kyei’s research has led to significant international visibility, with his team members winning travel awards to attend prestigious conferences, including the Keystone Symposium and the African Virology Congress. These opportunities have allowed them to present their findings and collaborate with global experts in the field.
Expanding horizons
The EDCTP-GSK Senior Fellowship grant has facilitated the groundwork for additional projects, including a newly awarded Fogarty grant aimed at enhancing HIV basic science and cure research training at the University of Ghana. This grant will train 17 researchers over the next 5 years, further strengthening the research landscape in Ghana.
As the team looks to the future, plans are in place to expand research into HIV reservoir characteristics among virologically suppressed patients across Ghana. This extension not only continues the momentum generated by the EDCTP grant, but also reinforces Ghana’s position as a leader in HIV cure research in Africa and contributes to the global effort to eradicate HIV.
Save The Date! Communications Workshop At The Edctp 2025 Forum
Dear Colleague,
Are you attending the EDCTP 2025 forum in Kigali (Rwanda)?
Don't miss the Communications workshop on Thursday 19 June (15:30 - 17:30 Rwanda time) in room MH3.
The topic of the workshop will be: "From good to great: Mastering communication skills for impactful science
Best,
The EDCTP team.
Call For Proposals: Panel Sessions At Science Forum South Africa 2025
Dear Stakeholder
Science Forum South Africa 2025 (SFSA 2025) will take place from 24 to 28 November 2025 at the CSIR International Convention Centre (CSIR ICC) in Pretoria, South Africa. This year marks the tenth edition of SFSA, celebrating a decade of igniting vibrant discussions on the role of science in society. The Forum brings together stakeholders from the scientific community, government, industry, and civil society.
We are pleased to invite proposals from individuals and institutions to convene panel sessions as part of the SFSA 2025 programme. These sessions should align with the Forum's theme and sub-themes, and provide an opportunity to engage diverse perspectives in critical conversations.
FORUM THEME
Igniting Conversations: Placing Science, Technology, and Innovation at the Centre of Government, Education, Society, and Industry
SUB-THEMES
- Financing for Science, Technology and Innovation (STI)
- Science and Society Nexus (Agriculture, Health, Climate Change, Just Energy Transition)
- Building Research Capabilities for Africa (STISA 2024)
- The Role of Science Diplomacy
- Emerging Industry – The Role of Disruptive Technologies
- Science Journalism and Science Communication
- Entrepreneurship and Innovation
HOW TO SUBMIT
The deadline for proposal submissions is 21 July 2025.
SFSA 2025 is proudly co-hosted by the South African Department of Science, Technology and Innovation (DSTI) and the Science Diplomacy Capital for Africa (SDCfA) initiative.
We look forward to your participation in shaping the dialogue at SFSA 2025.
Best regards
The SFSA 2025 Organising Committee